Search
Now showing results 1-1 of 1
- Sort Options:
- Relevance
- Title Asc
- Title Desc
- Date Issue Asc
- Date Issue Desc
- Date Accession Asc
- Date Accession Desc
- Results Per Page:
- 5
- 10
- 20
- 40
- 60
- 80
- 100
The Impact of Pazopanib on the Cardiovascular System
Justice, Cody; Kempton, Amber; Musa, Hassan; Lancione, Peter; Cefalu, Matt; Jenssen, Paul; Mohler, Peter; Ho, Thai (2017-09-14)
Background: Pazopanib was FDA-approved in 2009 and has become the first line of treatment for renal cell carcinoma. Pazopanib is a tyrosine kinase inhibitor that slows tumor growth and angiogenesis by its action on vascular ...